Companies:

 

Articles:

 

Biotech & Pharma

Cover Image for Neurizon Therapeutics confirms potential of NUZ-001 as platform therapy for ALS and Huntington’s disease

Neurizon Therapeutics confirms potential of NUZ-001 as platform therapy for ALS and Huntington’s disease

Cover Image for BPH Global books $150,000 in first-month revenue from Indonesian seaweed venture

BPH Global books $150,000 in first-month revenue from Indonesian seaweed venture

Cover Image for Singular Health secures PNS deal and finalises $8m placement for US expansion

Singular Health secures PNS deal and finalises $8m placement for US expansion

Cover Image for Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial

Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial

Cover Image for INOVIQ reports 88% kill rate of breast and lung cancer cells in CAR-exosome therapy study

INOVIQ reports 88% kill rate of breast and lung cancer cells in CAR-exosome therapy study

Cover Image for Emyria’s Empax PTSD trauma care program gains funding support from Medibank Private

Emyria’s Empax PTSD trauma care program gains funding support from Medibank Private

Cover Image for Amplia Therapeutics reports first pathological complete response in ACCENT pancreatic cancer trial

Amplia Therapeutics reports first pathological complete response in ACCENT pancreatic cancer trial

Cover Image for EVE Health and TeleDocs to launch online prescription service for erectile dysfunction and period pain treatments

EVE Health and TeleDocs to launch online prescription service for erectile dysfunction and period pain treatments

Cover Image for Syntara advances myelofibrosis trial with Phase 2 data and SNT-5505 FDA fast track designation

Syntara advances myelofibrosis trial with Phase 2 data and SNT-5505 FDA fast track designation

Cover Image for EVE Health Group completes takeover of Nextract, strengthens executive team

EVE Health Group completes takeover of Nextract, strengthens executive team

Cover Image for Cyclopharm granted maximum US market patent extension for Technegas imaging kit

Cyclopharm granted maximum US market patent extension for Technegas imaging kit

Cover Image for EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises

EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises

Cover Image for Chimeric Therapeutics gains FDA fast-track approval for CHM CDH17 gastrointestinal cancer candidate

Chimeric Therapeutics gains FDA fast-track approval for CHM CDH17 gastrointestinal cancer candidate

Cover Image for EVE Health Group begins stability testing of oral treatments for ED and period pain

EVE Health Group begins stability testing of oral treatments for ED and period pain

Cover Image for Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial

Invion advances skin cancer treatment with positive safety data for INV043 in Phase I/II trial

Cover Image for Immutep delivers major breakthrough with 59.6% response rate in lung cancer trial

Immutep delivers major breakthrough with 59.6% response rate in lung cancer trial

Cover Image for Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology

Optiscan Imaging and Mayo Clinic to collaborate on robotic breast cancer surgery technology

Cover Image for Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool

Memphasys pilot study confirms RoXsta’s potential as high-throughput antioxidant diagnostic tool

Cover Image for Algorae Pharmaceuticals teams with Peter MacCallum Centre to validate AI-predicted cancer drug synergies

Algorae Pharmaceuticals teams with Peter MacCallum Centre to validate AI-predicted cancer drug synergies

Cover Image for Clinuvel Pharmaceuticals reaches patient recruitment milestone ahead of Phase III Scenesse vitiligo trial

Clinuvel Pharmaceuticals reaches patient recruitment milestone ahead of Phase III Scenesse vitiligo trial

Cover Image for Immutep delivers strong survival results in efti-Keytruda head and neck cancer immunotherapy trial

Immutep delivers strong survival results in efti-Keytruda head and neck cancer immunotherapy trial

Cover Image for Dimerix and Amicus Therapeutics partner to commercialise kidney disease treatment DMX-200 in the US

Dimerix and Amicus Therapeutics partner to commercialise kidney disease treatment DMX-200 in the US

Cover Image for Aroa Biosurgery maintains cash flow momentum as Myriad Matrix product sales hit record high

Aroa Biosurgery maintains cash flow momentum as Myriad Matrix product sales hit record high

Cover Image for Algorae Pharmaceuticals strengthens drug pipeline as AlgoraeOS Version 2.0 development continues

Algorae Pharmaceuticals strengthens drug pipeline as AlgoraeOS Version 2.0 development continues

Cover Image for ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices

ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices

Cover Image for Orthocell appoints first four distributors for Remplir nerve repair technology in the US

Orthocell appoints first four distributors for Remplir nerve repair technology in the US

Cover Image for TruScreen Group launches five-year cervical cancer screening program in Ho Chi Minh City

TruScreen Group launches five-year cervical cancer screening program in Ho Chi Minh City

Cover Image for Prescient Therapeutics gains fast-track FDA designation for PTX-100 to treat T-cell lymphoma

Prescient Therapeutics gains fast-track FDA designation for PTX-100 to treat T-cell lymphoma

Cover Image for NeuroScientific Biopharmaceuticals acquires Isopogen to advance stem cell therapy for neurodegenerative disorders

NeuroScientific Biopharmaceuticals acquires Isopogen to advance stem cell therapy for neurodegenerative disorders

Cover Image for EVE Health Group expands into erectile dysfunction market with $3m takeover of Nextract

EVE Health Group expands into erectile dysfunction market with $3m takeover of Nextract

OSZAR »